Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm microtubule associated protein 2 (SPMAP2) is a testis-specific, microtubule-associated protein encoded by the SPMAP2 gene (HGNC:13706), expressed primarily in the nuclei of haploid male germ cells, particularly during spermatogenesis[1][4][7][8]. Its biological role appears to involve protein assembly, possibly through interactions with T-complex protein 1 subunit epsilon and other components integral to sperm formation and maturation[4]. Alternative splicing results in multiple isoforms, and the gene is evolutionarily conserved in mammals, but is not widely expressed outside of male germ cells[3][4][7]. Although sometimes classified among "cancer/testis antigens" due to its restricted expression, there are currently no known drugs, diagnostic biomarkers, or recognized safety issues directly linked to this protein, and no evidence supporting its direct involvement in common disease processes other than marginal literature mentions in axonal neuropathies[4].
None known. No drugs or modulators with described mechanisms regarding SPMAP2
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm microtubule associated protein 2 (SPMAP2).